Drug trials

"The Pharmaceutical Industry Has a Large Amount of Control Over the Field of Oncology"

In the second part of our two-part interview with Daniel Goldstein, MD, an oncologist who studies the influence of business interests on healthcare, we talk...

When Medical Experiments Serve the Business Needs of Pharmaceutical Firms Instead of Science

The first part of a two-part interview with Daniel Goldstein, MD, an oncologist who also studies the influence of business interests on healthcare—from treating patients...

LATEST NEWS

Democratize Work

An excerpt from a new book, Democratize Work: The Case for Reorganizing the Economy, advocates democratizing firms and decommodifying work.

Antitrust Enforcement, Inflation and Corporate Greed: What do we know?

At a recent Centre for Economic Policy Research (CEPR) event, panelists, including the Stigler Center's own Luigi Zingales, reflected on the roles...

Data is Abundant But is it Accessible to Researchers?

Despite the wide availability of data, ensuring independent access to data sources has never been more crucial. How can researchers engage in...

Private Labels in Online Marketplaces

On their store shelves, Walmart has its own products under the "Great Value” brand, and Tesco has its own “Everyday Value” products....

Bolsonaro’s reelection may become a setback for ESG in Brazil

Social pressures, market forces and elected leaders influence corporate decisions on environmental, social and governance (ESG) issues. Journalist Stephanie Tondo examines the...